Atlas Trials

Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions

Clinical trial NCT00616681 · COMPLETED

Trial details

NCT number
NCT00616681
Sponsor
Roxane Laboratories
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SeizuresEpilepsy
Start date
2004-06-01
Primary completion
2004-07-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.